YEA CHRISTOPHER (Chief Development Officer) sold 0.5% of their position (1.11K shares) of KALVISTA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $16.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/19/2026ACC: 0001691102-26-000001
Officer· Chief Development Officer
Since Sep 2018
-1.11K
Net shares
Net seller
$16.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.77K acquired · 2.88K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.77K
Price / share
—
Trade value
—
% of position
0.8%
2/17/2026
223.51K→225.28K
Common Stock
Direct
Shares
−1.11K
Price / share
$15.00
Trade value
$16.64K
% of position
0.5%
2/18/2026
225.28K→224.17K
Total
Net shares
+665.00
Net value
-$16.64K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/17/2026 | M · Option Exercise | +1.77K | — | — | 0.8% | 223.51K | 225.28K |
| Common Stock Direct | 2/18/2026 | S · Sale | −1.11K | $15.00 | $16.64K | 0.5% | 225.28K | 224.17K |
| Total | +665.00 | -$16.64K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
1.77K shares
Shares
−1.77K
Strike price
Held after
1.77K
Exercisable
—
2/17/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock1.77K shares | 2/17/2026 | M · Option Exercise | −1.77K | — | 1.77K |